The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

Summary

This study series consists of four related studies and aims to explore and describe many important elements of alopecia areata over three key areas: (1) the current epidemiology of alopecia areata, (2) the prevalence and incidence of psychiatric co-morbidities in people with alopecia areata, (3) the prevalence and incidence of autoimmune and atopic conditions in people with alopecia areata, and (4) the incidence of common infections in people with alopecia areata.

Conditions

• Alopecia Areata
• Depressive Episode
• Recurrent Depressive Disorder
• Anxiety Disorders
• Atopic Dermatitis
• Allergic Rhinitis
• Asthma
• Crohn Disease
• Ulcerative Colitis
• Pernicious Anemia
• Type 1 Diabetes
• Hashimoto Thyroiditis
• Graves Disease
• Rheumatoid Arthritis
• Psoriatic Arthritis
• Ankylosing Spondylitis
• Systemic Lupus Erythematosus
• Polymyalgia Rheumatica
• Sjogren's Syndrome
• Psoriasis
• Vitiligo
• Multiple Sclerosis
• Celiac Disease
• Upper Respiratory Tract Infection
• Influenza
• Lower Resp Tract Infection
• Acute Bronchitis
• Pneumonia
• Gastrointestinal Infection
• Skin Infection
• Urinary Tract Infections
• Genital Infection
• Herpes Zoster
• Herpes Simplex
• Infection
• Infection Viral

Interventions

OTHER

Exposure of interest (studies 2 & 3).

Common mental health conditions consist of depressive episodes, recurrent depressive disorder and anxiety disorder Atopic conditions consist of Atopic dermatitis, allergic rhinitis, asthma Autoimmune conditions consist of Crohn's disease, ulcerative colitis, Coeliac disease, Pernicious anaemia, Type 1 diabetes, Hashimoto's thyroiditis, Grave's disease, Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Systemic lupus erythematosus, polymyalgia rheumatica, Sjögren's syndrome, Psoriasis, vitiligo, Multiple sclerosis

Sponsors & Collaborators

• Pfizer

  collaborator INDUSTRY

• University of Surrey

  collaborator OTHER

• University of Oxford

  collaborator OTHER

• Momentum Data

  lead INDUSTRY

Principal Investigators

• Andrew McGovern, MD · Momentum Data

Eligibility

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2020-10-01

Primary Completion

2022-03-31

Completion

2022-11-28

Countries

• United Kingdom

Study Locations